PDF-Roche Position on Counterfeiting
Author : alexa-scheidler | Published Date : 2016-03-09
1 7 Background Counterfeiting pharmaceutical and diagnostic products is a criminal act which poses a significant global public health problem Counterfeit medicines
Presentation Embed Code
Download Presentation
Download Presentation The PPT/PDF document "Roche Position on Counterfeiting" is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
Roche Position on Counterfeiting: Transcript
1 7 Background Counterfeiting pharmaceutical and diagnostic products is a criminal act which poses a significant global public health problem Counterfeit medicines are mostly offered for sale by u. Roche Counterfeiting: Consumer Motivations, Emotions, and Awareness of Consequences. A . counterfeit product. is defined as an imitation, usually made with the intent of fraudulently passing it off as genuine. These products are often produced with the intent to take advantage of the established worth of the imitated product. Counterfeit products may carry exact logos or names of an authentic brand, but was not produced by the original brand.. Second WIPO Inter-Regional Meeting on South-South Cooperation on Patents, Trademarks, GI, Industrial Designs and Enforcement. Cairo, May 08, 2013. Secretariat of National Committee for IPRs. Ministry of Commerce, Cambodia. via Federated . RFID Tags’ . Diversities. Lei Yang. Tsinghua University. Pai. Peng, Fan Dang, Xiang-Yang Li, . Yunhao. Liu . D. iversity. Fingerprinting genuineness. 04.. Outline. Overview. 02.. Fingerprinting tags. . In the face of mounting counterfeiting, diversion & other infringements. Jim Mentone | Director, Consumer Global Brand Protection. Create active collaboration. g. roup . MFGs & Retailers. Noah Metheny, Esq., MPH. Director of Policy. July 25, 2012. AIDS 2012. Outline. Issue #1. : Global context of anti-counterfeiting measures. Issue #2. : Definition of counterfeit medicines: Conflation of generics with counterfeit medicines and impact on access. 1 1 on Similar Biotherapeutic Products – Biosimilars Similar Biotherapeutic Products – Biosimilars Innovative biotherapeutic products (e.g. proteins, monoclonal antibodies) are losing Notes. Aidan Roche. 2009. 1. (c) Aidan Roche 2009. Given the centre and radius of a circle, to find the equation of Circle K?. K. r. Method. Sub centre & radius into: . (x – h). 2. + (y – k). & Brand Protection. An Introduction to Our Speakers. Welcome. Counterfeiters . pose . a serious challenge to relatively all industries, in nearly every country. At IQPC’s cross-industry . 12th Anti-Counterfeiting & Brand Protection West Coast Summit. Notes. Aidan Roche. 2009. 1. (c) Aidan Roche 2009. Given the centre and radius of a circle, to find the equation of Circle K?. K. r. Method. Sub centre & radius into: . (x – h). 2. (y – k). Organisation for Economic Cooperation and Development (OECD) . concluded in a 2007 study that about 2% of world trade, with a value of about 176 billion (USD), is counterfeit. This number exceeds the Gross National Product (GNP) of entire economies such as Argentina (173 billion USD), Ireland (167 billion USD), Israel (129 billion USD) and Venezuela (128 billion USD) . “The role of a national Office in relation to enforcement of IPR – Danish Best Practice” Mexico City, November 13, 2018 By Janne Hedegaard ( jhw@dkpto.dk ) Principal project adviser Policy, Legal Affairs and International Projects In 1927, Mazo de la Roche (1879-1961), who had been living on what was part of the original Benares estate, in a building known as Trail Cottage,--near the present day corner of Jalna Avenue and Ravin GBSC F2F . meeting. ; . July. 21st 2018 Chicago. Aim. Investigate consistency between the CRM-adjusted concentrations, measured in CSF samples using different Beta-Amyloid 1-42 assays . Aim. Investigate consistency between the CRM-adjusted concentrations, measured in CSF samples using different Beta-Amyloid 1-42 assays .
Download Document
Here is the link to download the presentation.
"Roche Position on Counterfeiting"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.
Related Documents